Zhichao Fang
About Zhichao Fang
Zhichao Fang is a Senior Scientist II/Senior Principal Scientist at Bristol Myers Squibb, specializing in the development of antibodies, fusion proteins, and other biological molecules. He has extensive experience in cell line, upstream, and downstream process development, with a background in Pharmaceutical Sciences, Chemistry, and Applied Chemistry.
Current Role at Bristol Myers Squibb
Zhichao Fang currently holds the position of Senior Scientist II/Senior Principal Scientist at Bristol Myers Squibb in New Brunswick, New Jersey. Since joining the company in July 2014, Fang has been leading the Process Development Analytics group. His work primarily focuses on the development of antibodies, fusion proteins, and other biological molecules. His role involves extensive experience in cell line, upstream, and downstream process development.
Previous Experience at Xagenic Inc.
Before his tenure at Bristol Myers Squibb, Zhichao Fang worked as a Senior Principal Scientist at Xagenic Inc. from 2010 to 2014. During his four years with the company in Toronto, Canada, he was involved in significant projects related to the development of biological molecules. His experience at Xagenic Inc. provided a solid foundation for his current role in process development analytics.
Ph.D. in Pharmaceutical Sciences from University of Toronto
Zhichao Fang earned his Ph.D. in Pharmaceutical Sciences from the University of Toronto, completing his studies from 2007 to 2010. His doctoral education equipped him with advanced knowledge and expertise in pharmaceutical sciences, laying the groundwork for his subsequent professional career in the pharmaceutical industry.
Education in Chemistry from Boston College
Prior to his Ph.D., Fang studied Chemistry at Boston College from 2005 to 2006. This one-year program further augmented his scientific foundation, building essential skills and knowledge that support his role in the field of pharmaceutical sciences.
Undergraduate Studies at Peking University
Zhichao Fang completed his undergraduate studies at Peking University, earning a B.S. in Applied Chemistry from 2001 to 2005. This four-year degree provided him with a broad and solid base in applied chemistry, which has been integral to his professional expertise in pharmaceutical and biological molecule development.